BRIEF published on 03/22/2024 at 07:05, 1 year 8 months ago Relief Therapeutics Forms Exclusive Agreement with Eton Pharmaceuticals for PKU GOLIKE in the U.S. Relief Therapeutics Eton Pharmaceuticals PKU GOLIKE Biopharmaceutical Partnership Rare Metabolic Diseases
BRIEF published on 03/22/2024 at 07:05, 1 year 8 months ago Relief Therapeutics conclut un accord exclusif avec Eton Pharmaceuticals pour la PKU GOLIKE aux États-Unis Thérapeutique De Soulagement Eton Pharmaceutique PCU GOLIKE Partenariat Biopharmaceutique Maladies Métaboliques Rares
BRIEF published on 03/22/2024 at 07:05, 1 year 8 months ago CEWE Stiftung & Co. KGaA Announces Positive Financial Growth in 2023 and Optimistic Outlook for 2024 CEWE Stiftung & Co. KGaA Dividend Increase Photofinishing Financial Growth Online Printing
BRIEF published on 03/22/2024 at 07:05, 1 year 8 months ago CEWE Stiftung & Co. KGaA annonce une croissance financière positive en 2023 et des perspectives optimistes pour 2024 Croissance Financière CEWE Stiftung & Co. KGaA Augmentation Du Dividende Finition Photo Impression En Ligne
BRIEF published on 03/22/2024 at 07:05, 1 year 8 months ago ALSO Holding AG Announces Thirteenth Consecutive Dividend Increase Annual General Meeting Sustainable Growth Dividend Increase ALSO Holding AG Technology Provider
BRIEF published on 03/22/2024 at 07:05, 1 year 8 months ago ALSO Holding AG annonce une treizième augmentation consécutive de son dividende Augmentation Du Dividende Assemblée Générale Annuelle ALSO Holding SA Fournisseur De Technologie Une Croissance Durable
BRIEF published on 03/22/2024 at 07:05, 1 year 8 months ago BMW and World Woman Foundation Partner for 2024 'World Woman Hour' in Los Angeles Female Leadership Empowerment International Women's Day World Woman Hour BMW
BRIEF published on 03/22/2024 at 07:05, 1 year 8 months ago BMW et la World Woman Foundation s'associent pour la « World Woman Hour » 2024 à Los Angeles Leadership Féminin Journée Internationale De La Femme Autonomisation Heure Mondiale De La Femme BMW
BRIEF published on 03/22/2024 at 07:05, 1 year 8 months ago Biophytis dévoile son étude de phase 3 sur le traitement de la sarcopénie Biophytis Sarcopénie Ruvembri Étude De Phase 3 ICFSR
BRIEF published on 03/22/2024 at 07:05, 1 year 8 months ago Biophytis Unveils Phase 3 Sarcopenia Treatment Protocol Biophytis Clinical Research RuvembriTM Sarcopenia Phase 3 Study
Published on 12/08/2025 at 15:00, 23 minutes ago Optex Systems Holdings Announces Chad George as Chief Executive Officer
Published on 12/08/2025 at 15:00, 23 minutes ago Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025
Published on 12/08/2025 at 15:00, 23 minutes ago Goldcliff Confirms Potential for Non-Cyanide Gold Recovery at Panorama Ridge
Published on 12/08/2025 at 15:00, 23 minutes ago A*STAR, Tradepro, REDWAVE, and the Rise of a Verified Circular Economy Powered by SMX
Published on 12/08/2025 at 14:30, 53 minutes ago Unusual Machines and Dynamic Aerospace Systems Enter Supplier Agreement for U.S.-Made, NDAA-Compliant Drone Components
Published on 12/08/2025 at 15:05, 18 minutes ago Newmark Named North America's Best Real Estate Adviser by Euromoney
Published on 12/08/2025 at 14:53, 30 minutes ago EQS-Adhoc: Carl Zeiss Meditec AG: Termination of Maximilian Foerst’s Executive Board mandate as of 31 December 2025 and interim assumption of the CEO role by Andreas Pecher as of 1 January 2026
Published on 12/08/2025 at 14:50, 33 minutes ago Mirum Pharmaceuticals to acquire HBM portfolio company Bluejay Therapeutics for up to USD 820 million
Published on 12/08/2025 at 13:25, 1 hour 58 minutes ago BingX Introduces Major Copy Trading Upgrade, Marking 1.3 Billion Copy Orders
Published on 12/08/2025 at 13:00, 2 hours 23 minutes ago HKSTP Led Delegation of Innovators to Unlock Hong Kong-Italy Innovation Potential at Think Business Think Hong Kong in Milan
Published on 12/06/2025 at 13:26, 2 days 1 hour ago Total number of voting rights and shares making up the share capital at November30, 2025
Published on 12/05/2025 at 23:00, 2 days 16 hours ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
